May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Vitamin D Inhibits Retinal Neovascularization During Oxygen-Induced Ischemic Retinopathy and Retinal Endothelial Cell Capillary Morphogenesis in Culture
Author Affiliations & Notes
  • N. Sheibani
    Univ of Wisconsin-Madison, Madison, Wisconsin
    Ophthal and Visual Sci,
  • D. M. Albert
    Univ of Wisconsin-Madison, Madison, Wisconsin
    Ophthal and Visual Sci,
  • E. A. Scheef
    Univ of Wisconsin-Madison, Madison, Wisconsin
    Ophthal and Visual Sci,
  • S. R. Darjatmoko
    Univ of Wisconsin-Madison, Madison, Wisconsin
    Ophthal and Visual Sci,
  • C. M. Sorenson
    Univ of Wisconsin-Madison, Madison, Wisconsin
    Pediatrics,
  • Footnotes
    Commercial Relationships N. Sheibani, None; D.M. Albert, None; E.A. Scheef, None; S.R. Darjatmoko, None; C.M. Sorenson, None.
  • Footnotes
    Support EY13700 (NS), DK67120 (CMS) and EY01917 (DMA), and TIF-Robert Draper award from Wisconsin Alumni Research Foundation (NS). NS is a recipient of a Career Development Award from the Research to Prevent
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 1723. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. Sheibani, D. M. Albert, E. A. Scheef, S. R. Darjatmoko, C. M. Sorenson; Vitamin D Inhibits Retinal Neovascularization During Oxygen-Induced Ischemic Retinopathy and Retinal Endothelial Cell Capillary Morphogenesis in Culture. Invest. Ophthalmol. Vis. Sci. 2007;48(13):1723. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: Vitamin D compounds inhibit growth of a variety of tumors in preclinical and clinical studies. Among the mechanisms suggested for this inhibition is anti-angiogenesis. Retinal angiogenesis is the basis for vision loss in several major blinding diseases. Here the antiangiogenic activity of calcitriol (1,25-dihydroxyvitamin D3) in vivo and its effect on retinal endothelial cell (EC) proliferation, migration, and capillary morphogenesis in vitro were evaluated.

Methods:: The mouse oxygen-induced ischemic retinopathy (OIR) model was used to assess the antiangiogenic activity of calcitriol. The ocular VEGF levels were determined by Western blot analysis of whole eye extracts from P15 mice during OIR. The effects of calcitriol on retinal EC proliferation, migration, and capillary morphogenesis were also assessed in vitro.

Results:: Calcitriol-treated animals demonstrated a significant decrease in retinal neovascularization compared to control animals. This effect was dose-dependent and retinal neovascularization was significantly inhibited in calcitriol-treated mice. Although no mortality occurred with any of the doses examined, calcitriol administration resulted in a failure to gain weight. The ocular level of VEGF was similar in control and calcitriol-treated animals. At lower concentrations of calcitriol retinal EC capillary morphogenesis in Matrigel was inhibited without a significant effect on EC proliferation and migration. The concentration of calcitriol required to inhibit retinal EC proliferation was significantly higher than that required to inhibit their capillary morphogenesis.

Conclusions:: These data suggest that calcitriol is a potent inhibitor of retinal neovascularization and may be of benefit in the treatment of a variety of eye diseases with a neovascular component.

Keywords: retinal neovascularization • vascular cells • retinopathy of prematurity 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×